NEURAXES's ongoing commitment to peptide drug development represents a significant step forward in pharmaceutical innovation. Recent studies highlight promising results regarding new delivery methods, specifically targeting the central nervous system for chronic pain and neurological disorders. Thei

Emerging studies offer a spark of hope for individuals living with motor deficits. Targeted electrical stimulation – a technique involving the delivery of precise electrical currents to the spinal nerves – is showing remarkable results in improving movement in some patients. While still in its devel

More and more study suggests that biogenic peptide treatment represents a substantial evolution in modern clinical techniques. This type of functional molecules, sourced from natural origins, have been investigated for their promise to support cellular repair, here affect immune function and manage

Increasingly investigation suggests that short chain protein treatment represents a substantial shift in contemporary clinical methods. This type of small molecules, obtained from organic origins, are being explored for their ability to promote cellular restoration, modulate body's activity and add

NeuroAxes is actively investigating advanced peptide medicines for managing neurological illnesses. Recent studies focuses on enhancing peptide administration across the blood-brain barrier, utilizing distinctive technologies. These include alterations to peptide design and creation to increase bioa